Journal of Critical Care
Volume 23, Issue 1 , Pages 34-40 , March 2008

Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy

References 

  1. National Nosocomial Infections Surveillance System . National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;27:520–532
  2. Centers for Disease Control and Prevention . Monitoring hospital acquired infections to promote patient safety: United States, 1990-1999. MMWR Morb Mortal Wkly Rep. 2000;49:149–153
  3. American Thoracic Society Documents . Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416
  4. Gursel G. Determinants of the length of mechanical ventilation in patients with COPD in the intensive care unit. Respiration. 2005;72:61–67
  5. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case control study. Crit Care Med. 2001;29:2303–2309
  6. Bregeon F, Ciais V, Carret V, et al. Is ventilator-associated pneumonia an independent risk factor for death?. Anesthesiology. 2001;94:554–560
  7. Almirall J, Mesalles E, Klamburg J, et al. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest. 1995;107:511–516
  8. Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115:462–474
  9. Dominguez AA, Arango MV, Torres A. Treatment failure in patients with ventilator-associated pneumonia. Semin Respir Crit Care Med. 2006;27:104–113
  10. Ioanas M, Ferrer M, Cavalcanti M, et al. Causes and predictors of non-response to treatment of intensive care unit-acquired pneumonia. Crit Care Med. 2004;32:938–945
  11. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002;122:262–268
  12. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31:2742–2751
  13. Combes A, Luyt CE, Fagon JY, et al. for the PNEUMA Trial Group Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med. 2007;35:146–154
  14. Calandra T, Cohen J. International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The International Sepsis Forum Conference on Definitions of Infection in the Intensive Care Unit. Crit Care Med. 2005;33:1538–1548
  15. Van den Berghe G. Beyond diabetes: saving lives with insulin in the ICU. Int J Obesity. 2002;26(Suppl 3):S3–S8
  16. Vincent JL, Ferreira FL. Multiple organ failure: clinical syndrome. In:  Evans TW,  Fink MP editor. Update in intensive care and emergency medicine (38). Mechanisms of organ dysfunction in critical illness. Berlin Heidelberg: Springer-Verlag; 2002;p. 394–403
  17. Members of the American Collage of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee . American Collage of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–874
  18. Pugin J, Auckenthaler R, Mili N, et al. Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolaar lavage fluid. Am Rev Respir Dis. 1991;143:1121–1129
  19. Luna CM, Blanzaco D, Niederman MS, et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med. 2003;31:676–682
  20. Luna CM, Niederman MS. What is the natural history of resolution of nosocomial pneumonia?. Sem Resp Crit Care Med. 2002;5:471–479
  21. Luna CM, Aruj P, Niederman J, et al. for the Grupo Argentino de Estudio de la Neumonia Asociada al Respirador(GANAR) group Appropriateness and delay to initiate therapy in ventilator associated pneumonia. Eur Res J. 2006;27:158–164
  22. Dennesen PJ, van der Ven AJ, Kessels AG, et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001;163:1371–1375
  23. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis. 1993;147:38–44
  24. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588–2598
  25. Gursel G, Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator associated pneumonia. Respiration. 2006;73:503–508
  26. Rello J, Jubert P, Valles J, et al. Evaluation of outcome for intubated patients with pneumonia due to P. aeruginosa. Clin Infect Dis. 1997;23:973–978
  27. Leroy O, Meybek A, d’Escrivan T, et al. Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator associated pneumonia. Intensive Care Med. 2003;29:2170–2173
  28. Froon AH, Bonten M, Gaillard CA, et al. Prediction of clinical severity and outcome of ventilator associated pneumonia. Comparison of simplified acute physiology score with systemic inflammatory mediators. Am J Respir Crit Care Med. 1998;158:1026–1031
  29. Long C, Kinney J, Geiger J. Nonsupressibility of gluconeogenesis by glucose in septic patients. Metabolism. 1976;25:193–201
  30. Leverve X, Barnoud D, Pichard C. Nutritional support in acute respiratory failure. In: From Nutritional support to pharmacologic nutrition in the ICU. Update in intensive care and emergency medicine 34. Berlin Heidelberg: Springer-Verlag; 2000;p. 303–315
  31. Krishnan JA, Paice PB, Martinez S, et al. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest. 2003;124:297–305
  32. Le Tulzo Y, Pangault C, Gacouin A, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002;18:487–494
  33. Hotchkiss RS, Chang KC, Grayson MH, et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci U S A. 2003;100:6724–6729
  34. Schreiber T, Swanson PE, Chang KC, et al. Both Gram-negative and gram-positive experimental pneumonia induce profound lymphocyte but not respiratory epithelial cell apoptosis. Shock. 2006;26:271–276
  35. Combes A, Luyt CE, Fagon JY, et al. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator associated pneumonia. Am J Respir Crit Care Med. 2004;170:786–792
  36. Trouillet JL, Vuagnat A, Combes A, et al. Pseudomonas aeruginosa ventilator associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis. 2002;34:1047–1054
  37. Pittet D, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome nosocomial bloodstream infection: a 6 year, validated population-based model. Clin Infect Dis. 1997;24:1068–1078
  38. Luna C, Videla A, Matera J, et al. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in VAP. Chest. 1999;116:1075–1084

PII: S0883-9441(08)00020-8

doi: 10.1016/j.jcrc.2007.12.015

Journal of Critical Care
Volume 23, Issue 1 , Pages 34-40 , March 2008

Article Tools